Vitamin D status and seroconversion for COVID-19 in UK healthcare workers who isolated for COVID-19 like symptoms during the 2020 pandemic
Aduragbemi A Faniyi, Sebastian T Lugg, Sian E Faustini, Craig Webster, Joanne E Duffy, Martin Hewison, Adrian Shields, Peter Nightingale, Alex G Richter, Prof David R Thickett
doi:10.1101/2020.10.05.20206706
Background: It is clear that in UK healthcare workers, COVID-19 infections and deaths were more likely to be in staff who were of BAME origin. This has led to much speculation about the role of vitamin D in healthcare worker COVID-19 infections. We aimed to determine the prevalence of vitamin D deficiency in NHS staff who have isolated with symptoms suggestive of COVID-19 and relate this to vitamin D status.
Methods: We recruited NHS healthcare workers between 12 th to 22 nd May 2020 as part of the COVID-19 convalescent immunity study (COCO). We measured anti-SARS-Cov-2 antibodies using a combined IgG, IgA and IgM ELISA (The Binding Site). Vitamin D status was determined by measurement of serum 25(OH)D 3 using the AB SCIEX Triple Quad 4500 mass spectrometry system. Findings: Of the 392 NHS healthcare workers, 214 (55%) had seroconverted for COVID-19. A total of 61 (15.6%) members of staff were vitamin D deficient (<30 nmol/l) with significantly more staff from BAME backgrounds or in a junior doctor role being deficient. Vitamin D levels were lower in those who were younger, had a higher BMI (>30 kg/m 2 ), and were male. Multivariate analysis revealed that BAME and COVID-19 seroconversion were independent predictors of vitamin D deficiency. Staff who were vitamin D deficient were more likely to self-report symptoms of body aches and pains but importantly not the respiratory symptoms of cough and breathlessness. Vitamin D levels were lower in those COVID-19 positive staff who reported fever, but this did not reach statistical significance. Within the whole cohort there was an increase in seroconversion in staff with vitamin D deficiency compared to those without vitamin D deficiency (n=44/61, 72% vs n=170/331, 51%; p=0•003); this was particularly marked in the proportion of BAME males who were vitamin D deficient compared to non-vitamin D deficient BAME males (n=17/18, 94% vs n=12/23, 52%; p=0•005). Multivariate analysis revealed that vitamin D deficiency was an independent risk factor for seroconversion (OR 2•6, 95%CI 1•41-4•80; p=0•002). Interpretation: In those healthcare workers who have isolated due to symptoms of COVID-19, those of BAME ethnicity are at the highest risk of vitamin D deficiency. Vitamin D deficiency is a risk factor for COVID-19 seroconversion for NHS healthcare workers especially in BAME male staff.
References
Aspray, Bowring, Fraser, National Osteoporosis Society vitamin D guideline summary, Age Ageing
Baktash, Hosack, Patel, Vitamin D status and outcomes for hospitalised older patients with COVID-19, Postgrad Med J
Carpagnano, Lecce, Quaranta, Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J Endocrinol Invest
Castillo, Costa, Barrios, Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J Steroid Biochem Mol Biol
Chen, Zhou, Dong, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet
Dancer, Parekh, Lax, Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS), Thorax
Faustini, Jossi, Perez-Toledo, Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection, medRxiv
Ford, Graham, Wall, Berg, Vitamin D concentrations in an UK inner-city multicultural outpatient population, Ann Clin Biochem
Greiller, Martineau, Modulation of the immune response to respiratory viruses by vitamin D, Nutrients
Hastie, Mackay, Ho, Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr
Im, Je, Baek, Chung, Kwon et al., Nutritional status of patients with coronavirus disease 2019 (COVID-19), Int J Infect Dis
Kaufman, Niles, Kroll, Bi, Holick, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PLoS One
Mahida, Chotalia, Alderman, Characterization and Outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: A single center experience
Martineau, Jolliffe, Hooper, Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, Bmj
Merzon, Tworowski, Gorohovski, Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study, Febs j
Mitchell, Vitamin-D and COVID-19: do deficient risk a poorer outcome?, Lancet Diabetes Endocrinol
Panagiotou, Tee, Ihsan, Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity, Clin Endocrinol
Parekh, Dancer, Scott, Vitamin D to Prevent Lung Injury Following Esophagectomy-A Randomized, Placebo-Controlled Trial, Crit Care Med
Parekh, Patel, Scott, Vitamin D Deficiency in Human and Murine Sepsis, Crit Care Med
Parekh, Thickett, Turner, Vitamin D deficiency and acute lung injury, Allergy Drug Targets
Rhodes, Dunstan, Laird, Subramanian, Kenny, COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D, BMJ Nutrition, Prevention & Health
Shields, Faustini, Perez-Toledo, SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study, Thorax
Sowah, Fan, Dennett, Hagtvedt, Straube, Vitamin D levels and deficiency with different occupations: a systematic review, BMC Public Health
Watanabe, Allen, Wrapp, Mclellan, Crispin, Site-specific glycan analysis of the SARS-CoV-2 spike, Science
Webster, Relationship of total 25-OH vitamin D concentrations to Indices of Multiple Deprivation: geoanalysis of laboratory results, Ann Clin Biochem
Wrapp, Wang, Corbett, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science
DOI record:
{
"DOI": "10.1101/2020.10.05.20206706",
"URL": "http://dx.doi.org/10.1101/2020.10.05.20206706",
"abstract": "<jats:title>Summary</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>It is clear that in UK healthcare workers, COVID-19 infections and deaths were more likely to be in staff who were of BAME origin. This has led to much speculation about the role of vitamin D in healthcare worker COVID-19 infections. We aimed to determine the prevalence of vitamin D deficiency in NHS staff who have isolated with symptoms suggestive of COVID-19 and relate this to vitamin D status.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We recruited NHS healthcare workers between 12<jats:sup>th</jats:sup>to 22<jats:sup>nd</jats:sup>May 2020 as part of the COVID-19 convalescent immunity study (COCO). We measured anti-SARS-Cov-2 antibodies using a combined IgG, IgA and IgM ELISA (The Binding Site). Vitamin D status was determined by measurement of serum 25(OH)D<jats:sub>3</jats:sub>using the AB SCIEX Triple Quad 4500 mass spectrometry system.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Of the 392 NHS healthcare workers, 214 (55%) had seroconverted for COVID-19. A total of 61 (15.6%) members of staff were vitamin D deficient (<30 nmol/l) with significantly more staff from BAME backgrounds or in a junior doctor role being deficient. Vitamin D levels were lower in those who were younger, had a higher BMI (>30 kg/m<jats:sup>2</jats:sup>), and were male. Multivariate analysis revealed that BAME and COVID-19 seroconversion were independent predictors of vitamin D deficiency. Staff who were vitamin D deficient were more likely to self-report symptoms of body aches and pains but importantly not the respiratory symptoms of cough and breathlessness. Vitamin D levels were lower in those COVID-19 positive staff who reported fever, but this did not reach statistical significance. Within the whole cohort there was an increase in seroconversion in staff with vitamin D deficiency compared to those without vitamin D deficiency (n=44/61, 72%<jats:italic>vs</jats:italic>n=170/331, 51%; p=0·003); this was particularly marked in the proportion of BAME males who were vitamin D deficient compared to non-vitamin D deficient BAME males (n=17/18, 94%<jats:italic>vs</jats:italic>n=12/23, 52%; p=0·005). Multivariate analysis revealed that vitamin D deficiency was an independent risk factor for seroconversion (OR 2·6, 95%CI 1·41–4·80; p=0·002).</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>In those healthcare workers who have isolated due to symptoms of COVID-19, those of BAME ethnicity are at the highest risk of vitamin D deficiency. Vitamin D deficiency is a risk factor for COVID-19 seroconversion for NHS healthcare workers especially in BAME male staff.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>This study was funded internally by the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust and supported by the National Institute for Health Research (NIHR)/Wellcome Trust Birmingham Clinical Research Facility. AAF and DRT are funded by the Medical Research Council (MR/S002782/1). The Binding Site (Edgbaston, UK) have provided reagents and plates for the SARS-CoV-2 ELISA free of charge.</jats:p></jats:sec><jats:sec><jats:title>Research in context</jats:title><jats:sec><jats:title>Evidence before this study</jats:title><jats:p>The ongoing COVID-19 pandemic has raised several questions, one of which is whether individuals with vitamin D deficiency were at a greater risk of being infected or having a severe outcome if infected. Among UK healthcare workers, and indeed the general population, individuals of BAME ethnicity are disproportionately affected by COVID-19. It is well established that individuals of BAME ethnicity have a higher prevalence of vitamin D deficiency, but it is unknown if vitamin D deficiency among UK NHS workers was connected to the risk of COVID-19 infection. Our search of the literature revealed no previous studies have established the prevalence of vitamin D deficiency within a UK NHS trust. Unsurprisingly, there is also no evidence to suggest if vitamin D deficiency was connected to the risk of infection among UK healthcare workers.</jats:p></jats:sec><jats:sec><jats:title>Added value of this study</jats:title><jats:p>In this study of healthcare workers who had isolated for COVID-19 symptoms towards the end of UK surge within a large UK NHS trust, 15.6% were vitamin D deficient. Our data also reveal that healthcare workers of BAME ethnicity and those who had seroconverted for COVID-19 were more likely to be vitamin D deficient. Multivariate analysis also show that vitamin D deficiency was the only predictor of COVID-19 seroconversion. Vitamin D deficient healthcare workers that are BAME and male had a 94% seroconversion for COVID-19 compared to non-deficient BAME males suggesting they are more at risk of COVID-19 if vitamin D deficient.</jats:p></jats:sec><jats:sec><jats:title>Implications of all the available evidence</jats:title><jats:p>There is an increased risk of COVID-19 infection in healthcare workers with vitamin D deficiency. Our data adds to the emerging evidence from studies in the UK and across the globe that individuals with severe COVID-19 are more vitamin D deficient than those with mild disease. Finally, ours and the available evidence demonstrate vitamin D supplementation in individuals at risk of vitamin D deficiency or shown to be deficient may help alleviate the impact of COVID-19.</jats:p></jats:sec></jats:sec>",
"accepted": {
"date-parts": [
[
2020,
10,
6
]
]
},
"author": [
{
"affiliation": [],
"family": "Faniyi",
"given": "Aduragbemi A",
"sequence": "first"
},
{
"affiliation": [],
"family": "Lugg",
"given": "Sebastian T",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Faustini",
"given": "Sian E",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Webster",
"given": "Craig",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Duffy",
"given": "Joanne E",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Hewison",
"given": "Martin",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Shields",
"given": "Adrian",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Nightingale",
"given": "Peter",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Richter",
"given": "Alex G",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Thickett",
"given": "David R",
"sequence": "additional"
}
],
"container-title": [],
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2020,
10,
6
]
],
"date-time": "2020-10-06T18:20:33Z",
"timestamp": 1602008433000
},
"deposited": {
"date-parts": [
[
2021,
4,
6
]
],
"date-time": "2021-04-06T12:41:51Z",
"timestamp": 1617712911000
},
"group-title": "Endocrinology (including Diabetes Mellitus and Metabolic Disease)",
"indexed": {
"date-parts": [
[
2024,
4,
8
]
],
"date-time": "2024-04-08T08:36:14Z",
"timestamp": 1712565374758
},
"institution": [
{
"name": "medRxiv"
}
],
"is-referenced-by-count": 7,
"issued": {
"date-parts": [
[
2020,
10,
6
]
]
},
"link": [
{
"URL": "https://syndication.highwire.org/content/doi/10.1101/2020.10.05.20206706",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "246",
"original-title": [],
"posted": {
"date-parts": [
[
2020,
10,
6
]
]
},
"prefix": "10.1101",
"published": {
"date-parts": [
[
2020,
10,
6
]
]
},
"publisher": "Cold Spring Harbor Laboratory",
"reference": [
{
"key": "2020101914500680000_2020.10.05.20206706v1.1",
"unstructured": "WHO Coronavirus Disease (COVID-19) Dashboard. 2020. https://covid19.who.int/ (accessed Oct 5, 2020)."
},
{
"DOI": "10.3390/nu7064240",
"doi-asserted-by": "publisher",
"key": "2020101914500680000_2020.10.05.20206706v1.2"
},
{
"DOI": "10.1136/thoraxjnl-2014-206680",
"doi-asserted-by": "publisher",
"key": "2020101914500680000_2020.10.05.20206706v1.3"
},
{
"DOI": "10.1097/CCM.0000000000002095",
"article-title": "Vitamin D Deficiency in Human and Murine Sepsis",
"doi-asserted-by": "crossref",
"first-page": "282",
"issue": "2",
"journal-title": "Crit Care Med",
"key": "2020101914500680000_2020.10.05.20206706v1.4",
"volume": "45",
"year": "2017"
},
{
"DOI": "10.1016/S0140-6736(20)30211-7",
"doi-asserted-by": "publisher",
"key": "2020101914500680000_2020.10.05.20206706v1.5"
},
{
"DOI": "10.1097/CCM.0000000000003405",
"article-title": "Vitamin D to Prevent Lung Injury Following Esophagectomy-A Randomized, Placebo-Controlled Trial",
"doi-asserted-by": "crossref",
"first-page": "e1128",
"issue": "12",
"journal-title": "Crit Care Med",
"key": "2020101914500680000_2020.10.05.20206706v1.6",
"volume": "46",
"year": "2018"
},
{
"DOI": "10.1016/S2213-8587(20)30183-2",
"article-title": "Vitamin-D and COVID-19: do deficient risk a poorer outcome?",
"doi-asserted-by": "crossref",
"first-page": "570",
"issue": "7",
"journal-title": "Lancet Diabetes Endocrinol",
"key": "2020101914500680000_2020.10.05.20206706v1.7",
"volume": "8",
"year": "2020"
},
{
"key": "2020101914500680000_2020.10.05.20206706v1.8",
"unstructured": "Office for National Statistics. Coronavirus (COVID-19) related deaths by ethnic group, England and Wales: 2 March 2020 to 10 April 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/coronavirusrelateddeathsbyethnicgroupenglandandwales/2march2020to10april2020 (accessed Oct 5, 2020)."
},
{
"DOI": "10.1136/bmjnph-2020-000110",
"doi-asserted-by": "crossref",
"key": "2020101914500680000_2020.10.05.20206706v1.9",
"unstructured": "Rhodes J , Dunstan F , Laird E , Subramanian S , Kenny RA . COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D. BMJ Nutrition, Prevention & Health 2020: bmjnph-2020-000110."
},
{
"key": "2020101914500680000_2020.10.05.20206706v1.10",
"unstructured": "Exclusive: deaths of NHS staff from covid-19 analysed. 2020. https://www.hsj.co.uk/exclusive-deaths-of-nhs-staff-from-covid-19-analysed/7027471.article (accessed Oct 5, 2020)."
},
{
"DOI": "10.1186/s12889-017-4436-z",
"article-title": "Vitamin D levels and deficiency with different occupations: a systematic review",
"doi-asserted-by": "crossref",
"first-page": "519",
"issue": "1",
"journal-title": "BMC Public Health",
"key": "2020101914500680000_2020.10.05.20206706v1.11",
"volume": "17",
"year": "2017"
},
{
"DOI": "10.1136/thoraxjnl-2020-215414",
"doi-asserted-by": "crossref",
"key": "2020101914500680000_2020.10.05.20206706v1.12",
"unstructured": "Shields A , Faustini SE , Perez-Toledo M , et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax 2020."
},
{
"DOI": "10.1101/2020.06.16.20133025",
"doi-asserted-by": "crossref",
"key": "2020101914500680000_2020.10.05.20206706v1.13",
"unstructured": "Faustini SE , Jossi SE , Perez-Toledo M , et al. Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection. medRxiv 2020."
},
{
"key": "2020101914500680000_2020.10.05.20206706v1.14",
"unstructured": "Binding Site . Human Anti-IgG/A/M SARS-CoV-2 ELISA / Performance Characteristics / Clinical Performance. 2020. https://www.bindingsite.com/en/our-products/covid-19/sars-cov-2-elisa/performance-characteristics/clinical-performance (accessed Oct 5, 2020)."
},
{
"DOI": "10.1126/science.abb9983",
"doi-asserted-by": "publisher",
"key": "2020101914500680000_2020.10.05.20206706v1.15"
},
{
"DOI": "10.1126/science.abb2507",
"doi-asserted-by": "publisher",
"key": "2020101914500680000_2020.10.05.20206706v1.16"
},
{
"key": "2020101914500680000_2020.10.05.20206706v1.17",
"unstructured": "Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press 2011"
},
{
"DOI": "10.1093/ageing/afu093",
"doi-asserted-by": "publisher",
"key": "2020101914500680000_2020.10.05.20206706v1.18"
},
{
"DOI": "10.1258/000456306778904614",
"doi-asserted-by": "publisher",
"key": "2020101914500680000_2020.10.05.20206706v1.19"
},
{
"DOI": "10.1258/acb.2012.011249",
"doi-asserted-by": "publisher",
"key": "2020101914500680000_2020.10.05.20206706v1.20"
},
{
"DOI": "10.21203/rs.3.rs-49674/v1",
"doi-asserted-by": "crossref",
"key": "2020101914500680000_2020.10.05.20206706v1.21",
"unstructured": "Mahida RY , Chotalia M , Alderman J , et al. Characterization and Outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: A single center experience. Research Square 2020."
},
{
"DOI": "10.1371/journal.pone.0239252",
"article-title": "SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels",
"doi-asserted-by": "crossref",
"first-page": "e0239252",
"issue": "9",
"journal-title": "PLoS One",
"key": "2020101914500680000_2020.10.05.20206706v1.22",
"volume": "15",
"year": "2020"
},
{
"DOI": "10.1101/2020.07.01.20144329",
"doi-asserted-by": "crossref",
"key": "2020101914500680000_2020.10.05.20206706v1.23",
"unstructured": "Merzon E , Tworowski D , Gorohovski A , et al. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. Febs j 2020."
},
{
"DOI": "10.1136/bmj.i6583",
"doi-asserted-by": "publisher",
"key": "2020101914500680000_2020.10.05.20206706v1.24"
},
{
"DOI": "10.1136/postgradmedj-2020-138712",
"doi-asserted-by": "crossref",
"key": "2020101914500680000_2020.10.05.20206706v1.25",
"unstructured": "Baktash V , Hosack T , Patel N , et al. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J 2020."
},
{
"DOI": "10.2174/18715281113129990049",
"doi-asserted-by": "publisher",
"key": "2020101914500680000_2020.10.05.20206706v1.26"
},
{
"DOI": "10.1111/cen.14310",
"doi-asserted-by": "crossref",
"key": "2020101914500680000_2020.10.05.20206706v1.27",
"unstructured": "Panagiotou G , Tee SA , Ihsan Y , et al. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol (Oxf) 2020."
},
{
"DOI": "10.1007/s40618-020-01370-x",
"doi-asserted-by": "crossref",
"key": "2020101914500680000_2020.10.05.20206706v1.28",
"unstructured": "Carpagnano GE , Di Lecce V , Quaranta VN , et al. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J Endocrinol Invest 2020: 1–7."
},
{
"DOI": "10.1016/j.ijid.2020.08.018",
"doi-asserted-by": "crossref",
"key": "2020101914500680000_2020.10.05.20206706v1.29",
"unstructured": "Im JH , Je YS , Baek J , Chung MH , Kwon HY , Lee JS . Nutritional status of patients with coronavirus disease 2019 (COVID-19). Int J Infect Dis 2020."
},
{
"DOI": "10.1016/j.dsx.2020.04.050",
"article-title": "Vitamin D concentrations and COVID-19 infection in UK Biobank",
"doi-asserted-by": "crossref",
"first-page": "561",
"issue": "4",
"journal-title": "Diabetes Metab Syndr",
"key": "2020101914500680000_2020.10.05.20206706v1.30",
"volume": "14",
"year": "2020"
},
{
"article-title": "“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”. J Steroid Biochem",
"first-page": "105751",
"journal-title": "Mol Biol",
"key": "2020101914500680000_2020.10.05.20206706v1.31",
"volume": "203",
"year": "2020"
}
],
"reference-count": 31,
"references-count": 31,
"relation": {},
"resource": {
"primary": {
"URL": "http://medrxiv.org/lookup/doi/10.1101/2020.10.05.20206706"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subtitle": [],
"subtype": "preprint",
"title": "Vitamin D status and seroconversion for COVID-19 in UK healthcare workers who isolated for COVID-19 like symptoms during the 2020 pandemic",
"type": "posted-content"
}